drugset / Trial / NCT03373903
Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to evaluate the efficacy, tolerability, and safety of BEZ235 alone and in combination with RAD001 to support further development to reduce the incidence of respiratory tract infections (RTIs) in elderly subjects.
Timeline
- Start
- 2017-11-15
- Primary completion
- 2018-05-03
- Completion
- 2018-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dactolisib | Small molecule | 5 mg | Oral |
| Subject | Dactolisib | Small molecule | 10 mg | Oral |
| Subject | Everolimus | Small molecule | 0.1 mg | Oral |